ANGSTRO-TECHNOLOGY
Live / Applied — Third extension granted (statement of use) (as of 14 Nov 2025)
What this means for you
Not registered yet, but its 22 May 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98006538
- Mark type
- Stylized text
- Filed
- 22 May 2023
- Published for opposition
- 19 Mar 2024
- Attorney of record
- Francis J. Duffin
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of sleep disorders, fibromyalgia, post-traumatic stress disorder, functional somatic disorder, addiction, alcoholism, disorders of the nervous system, disorders of the musculo-skeletal system, disorders of the endocrine system, disorders of the musculoskeletal system, neurological disorders, hormonal disorder, psychiatric related diseases and disorders
Owner
- TONIX PHARMACEUTICALS, INC., Chatham, NJ, US
- TONIX PHARMACEUTICALS, INC., Chatham, NJ, US
Prosecution history
- 15 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Nov 2025 — SOU EXTENSION 3 GRANTED
- 14 Nov 2025 — SOU EXTENSION 3 FILED
- 14 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 13 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 May 2025 — SOU EXTENSION 2 GRANTED
- 12 May 2025 — SOU EXTENSION 2 FILED
- 12 May 2025 — SOU TEAS EXTENSION RECEIVED
- 09 Dec 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Dec 2024 — SOU EXTENSION 1 GRANTED
- 11 Nov 2024 — SOU EXTENSION 1 FILED
- 09 Dec 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 11 Nov 2024 — SOU TEAS EXTENSION RECEIVED
- 14 May 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 19 Mar 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED